VerityRank

Industry Report

Top 10 Edible Mushrooms Brands

October 2026·VerityRank Research Team

Mushrooms are the one fresh produce category in which the crop itself is manufactured rather than harvested, raised in rooms whose temperature, humidity and carbon dioxide are set by machine, on substrate mixed to a recipe, from spawn grown in a laboratory; the ten businesses on this page are factories that happen to sell food.

Nothing else on the produce shelf behaves this way. Composted straw, poultry litter, sawdust and bran are prepared, pasteurised and packed into beds, bags or bottles, liquid spawn is run into the substrate, and the crop fruits on a fixed cycle in a climate-controlled room that can be switched to another species by changing the recipe. Production is scheduled rather than seasonal, capacity is counted in tonnes per day rather than in hectares, and picking, grading and packing happen under one roof. Asia-Pacific takes between 78.7% and 79.69% of world consumption, Europe about 14.6% and North America about 7%, with published forecasts of compound annual growth between 7.13% and 10.1% through the mid-2030s.

Because the growing room is a machine, the heaviest weight in this index falls on industrial scale rather than on land. Bottle and bag systems, liquid spawn, automated filling and AI vision sorting have broken the old link between output and headcount: Hokuto Corporation, Shanghai Snowey Bio-Technology and Gansu Zongxing Mushroom Technology have cut the labour needed per tonne of mushrooms by more than 70%. That is why global sales and revenue scale carry 40% and purity carries 25%, while supply-chain control with production base size carries 15%: a tonne of enoki or button mushrooms is a manufactured unit with a name on the pack, and whoever owns the growing room, the substrate plant and the refrigerated route keeps a margin a field grower never sees.

The industry is running two cost curves at once, and the distance between them is a wage rate and a kilowatt hour. Monterey Mushroom Holdings, LLC closed its Royal Oaks farm in California, 275 acres and 605 workers, moved that volume to Morgan Hill and farms in other states after also shutting sites in Illinois and Florida, and took a US$22 million senior secured facility for automation; about 2,000 people work there today. On the other curve Hokuto spends on AI picking robots and breeding, while Snowey and Zongxing keep building climate-controlled rooms fed by liquid spawn. The squeeze runs both ways: Costa absorbs Australian electricity prices and drought or flood risk, and OKECHAMP S.A. faces tightening European environmental rules alongside Polish wages that no longer look cheap.

Purity is the second fault line, and the spread runs from almost total focus to a minority share of a diversified group. Gansu Zongxing draws about 99% of its revenue from mushrooms, Monterey about 98%, Shanghai Finc Bio-Tech Inc. about 98%, Snowey about 96%, Monaghan Mushrooms Ireland Unlimited Company about 95% and South Mill Champs LLC about 95%, Yukiguni Maitake about 94%, Hokuto about 88% with the balance in agricultural packaging and machinery, and OKECHAMP about 85% once its canned and frozen vegetable lines are counted. Costa Group Holdings is the outlier: its mushroom division is entirely mushrooms but supplies roughly a fifth of group revenue, so its US$280 million reads as a business inside a horticultural group.

Ownership decides how much a reader can verify, and this group splits four listed against six private. All four listings sit in Tokyo or Shenzhen: Hokuto on the Tokyo Stock Exchange Prime Market under 1379, Yukiguni Maitake on the same market under 1375, Snowey on the Shenzhen ChiNext board under 300511 and Zongxing on the Shenzhen main board under 002772. Monaghan is family controlled, Monterey and OKECHAMP are privately held, South Mill Champs is private-equity controlled, Finc left China's New Third Board, and Costa was taken private by a consortium. VerityRank tests the current Fortune Global 500 list, and none of the ten is a Fortune Global 500 member — nor does any clear that list's entry line on its own accounts — so the 90-point ceiling is untouched: the top score is 89 and the tenth place 77. No entrant is credited with the scale of an investor or a joint-venture partner.

Read by region, the ten are three different industries sharing one shelf. Japan sells technique and premium species: Hokuto runs 19 production centres across five countries and regions and about 75,000 tonnes a year, while Yukiguni Maitake grows about 55,000 tonnes from 11 plants in Niigata and holds the largest share of Japan's maitake market. China sells scale and cost: Snowey runs 18 industrialised bases at more than 1,350 tonnes a day, about 480,000 tonnes a year; Zongxing runs 16 bases and over 360,000 tonnes a year, button mushrooms near 300 tonnes a day and enoki above 700; Finc works five intelligent bases and exports to 30-plus countries. Europe and North America sell agaricus at industrial scale with compost attached: Monaghan owns 12 farms and compost plants across six countries and passes 200,000 tonnes a year, Monterey seven sites and about 130,000 tonnes, South Mill Champs more than 85,000 tonnes, and OKECHAMP over 65,000 tonnes from three plants.

Spent substrate has stopped being a disposal cost and become a product, and the retailers that pay best now treat that as a condition of supply. Monterey markets COSMC, an organically certified compost made from already-fruited material, to growers in California; Monaghan recovers biomass energy to cut the gas burned in its growing rooms and has moved to fully recyclable paper and bio-based packaging. European and North American rules on carbon footprints and agricultural waste have turned compost recovery, carbon certification and packaging recyclability into an entry requirement for chains such as Whole Foods and Tesco, so a grower in China or Poland now prices the fate of its own substrate into the offer it makes.

The verified problems in this group are financial, specific and recurring, and they sit inside a revenue range spanning a factor of about seven. Monaghan, the largest of the ten, reports about US$1.15 billion for 2025, Yukiguni about US$320 million for the year ending March 2026 and Finc the least at about US$160 million; Zongxing reached RMB 2.098 billion, up 8.43%. Snowey lost RMB 617 million in 2024 before forecasting a return to profit of RMB 29 million to 40 million for 2025, and still carries heavy depreciation. Monaghan is squeezed by British and European labour costs and by volatile straw and poultry-litter prices, Hokuto by Japanese electricity and imported woodchips, Yukiguni by substrate and freight costs that have compressed core EBITDA, OKECHAMP by European regulation and Polish wages, Finc by a domestic price war and no published accounts, South Mill Champs by cross-border freight, and Zongxing by local planning decisions affecting new production lines.

Cultivated Mushroom Brand Authority Index
VerityRank scores edible mushroom brands on five weighted dimensions:
• Global Sales and Revenue Scale (40%): mushroom revenue in US dollars, the branded volume behind it and the markets served.
• Mushroom Revenue Purity (25%): the share of turnover from cultivated mushrooms and mushroom-derived ingredients rather than other crops or unrelated business.
• Supply-Chain Control and Production Base Scale (15%): owned growing rooms, compost and substrate plants, daily and annual capacity, countries of operation and automation.
• Global Brand Influence (10%): recognition under the consumer brand, retail and foodservice listings, and export breadth.
• Capital Transparency and ESG (10%): quality of published reporting, exchange listing tier and verifiable progress on spent-substrate recovery and packaging. The scale ceiling is 90, reserved for companies that clear the Fortune Global 500 entry line on their own accounts — US$32.2 billion of revenue for the 2025 edition; no entrant qualifies, so the top score here is 89.

Data Sources
Principal sources include Hokuto shareholder notice, Snowey earnings forecast, Zongxing 2025 results coverage, Yukiguni Maitake Q2 FY2025/2026 disclosure, Monaghan Group disclosures, Gibraltar Business Capital facility notice, reporting on the Royal Oaks closure, OKECHAMP disclosures and the Fortune Global 500; private entrants rest on company statements and named trade reporting.

Disclaimer: Data comes from audited statements, exchange filings, company publications and named reporting. VerityRank receives no compensation from any company for inclusion, exclusion or position. Figures are stated in each company's own currency with dollar equivalents approximate, fiscal years end on different dates, and the Hokuto and Yukiguni figures are the companies' own forecasts for the year ending March 2026. Six of the ten are privately held, family controlled or investor controlled, and where such a company publishes nothing the entry says so; a quoted estimate is attributed to its publisher. No company inherits standing from a parent, an owner or a licensor, and Fortune Global 500 membership is never inferred from revenue. Contract packing, licensed varieties and traded goods are treated as distinct from the operating revenue of the company being scored.

Top 10 Rankings

Edition 2026.11

Monaghan Mushrooms Ireland Unlimited Company is an Irish grower, compost maker and processor of cultivated mushrooms, trading under the brand Monaghan Mushrooms within the wider Monaghan Group. Founded in 1981 at Tyholland in County Monaghan, it was built around button mushrooms and has extended since into brown and portabella types, organic crops, protein powders and extracts, and a bio-technology arm branded MBIO. The group is family controlled and unlisted. Monaghan Mushrooms is not a Fortune Global 500 company; revenue of about US$1.15 billion in 2025 is a fraction of the threshold used to draw up the 2025 list.

The company began as a family mushroom farm in County Monaghan, a border region with an existing growing tradition and easy access to the British market. Growth came from building and acquiring farms rather than franchising: compost production was brought in house, followed by owned growing rooms, packing lines and refrigerated transport, and by the 1990s the business supplied British and continental European retailers directly. Dutch, Belgian and German operations and a Canadian business followed, giving the group year-round supply and a second currency base. The MBIO division is the most recent layer.

The product line is built on the agaricus family: white button mushrooms, brown or cremini types and the larger portabella, sold fresh and pre-packed for retail, alongside organic crops grown to certification. Processing extends the same raw material into sliced and prepared packs, mushroom protein powders and extracts, including selenium-enriched mushrooms and plant-based vitamin D ingredients commercialised through MBIO. The mix matters commercially: fresh mushrooms are priced as a commodity by retail buyers, while extracts and ingredient powders sell into health and food-manufacturing markets where dried mushroom solids carry far higher value per kilo.

Production is vertically integrated to an unusual degree. The group operates 12 large vertically integrated farms and compost substrate plants, and controls the sequence from substrate manufacture and liquid inoculation through climate-controlled growing, harvesting, packing and cold-chain transport. Compost and casing are made in house, removing a bought-in cost and a quality variable most growers cannot avoid. Annual output exceeds 200,000 tonnes, and the growing platform spans six countries: Ireland, the United Kingdom, the Netherlands, Canada, Belgium and Germany.

Selling runs through retail and food-service supply rather than consumer advertising, so the Monaghan name is better known to category buyers than to shoppers. The geographic spread is weighted towards markets where fresh mushroom consumption is mature, chiefly the United Kingdom, Ireland and continental Europe, with Canadian capacity serving North American demand. On sustainability, the group moved to 100 per cent recyclable paper and bio-based packaging across its European operations in 2025 and 2026, and biomass recovery has cut natural gas use in the growing rooms.

The assessment is positive but qualified. Vertical integration gives Monaghan cost and quality control smaller competitors cannot match, and MBIO offers an option on higher-margin ingredient demand. The near-term outlook, however, is dominated by cost: labour costs in the United Kingdom and Europe have risen, and compost inputs such as straw and poultry litter have been volatile in price, squeezing a business whose fresh product is bought by retailers on annual terms. At this scale the group has less room than a listed rival to absorb those swings.

Unlisted

Founded

1981

Workforce

3,500

Facilities

12 vertically integrated farms and compost substrate plants

Presence

6 countries (Ireland, UK, Netherlands, Canada, Belgium, Germany)

HQ

Ireland

Type

Brand

Market

Unlisted

Agricultural ProductsAgricultural Products BrandsAgricultural Products Suppliers
2Monterey Mushroom Holdings, LLC

Monterey Mushroom Holdings, LLC, which trades as Monterey Mushrooms, is a United States grower, packer and distributor of fresh cultivated mushrooms. Founded in 1971 and based in Watsonville in Santa Cruz County, California, it grows white, brown and portabella types, markets organic and vitamin D-enhanced lines, and converts spent growing substrate into certified organic compost. The company is privately held and unlisted. Monterey Mushrooms is not a Fortune Global 500 company; revenue of about US$650 million in 2025 is a small fraction of the threshold used for the 2025 list, and it is not a subsidiary of one either.

The business dates from 1971 and was built in the California coastal belt around Watsonville and Morgan Hill, where cool marine air and proximity to the produce trade of the Pajaro and Salinas valleys favoured year-round mushroom growing. From that base it expanded by adding farms and distribution points rather than by acquiring brands, and it is now one of the largest fresh mushroom growers in North America. Ownership is private and the company publishes no audited accounts, so its outside visibility comes mainly from trade coverage and from the financing it arranges.

The fresh line-up covers the three commercial agaricus types, white mushrooms, brown or Baby Bella and the larger portabella, together with organic crops and mushrooms enriched with vitamin D using a patented ultraviolet treatment. That treatment is the clearest product differentiator the company holds: it raises vitamin D content in the harvested crop without additives, and it lets retail packs carry a nutrient claim that commodity mushrooms cannot. Composting is the third activity, turning spent substrate from the farms into organic soil amendments sold to Californian growers.

Production runs through 7 large smart production sites and distribution centres, spread across California, Texas, Pennsylvania and Illinois, with further capacity in Mexico. The layout places growing close to major metropolitan markets and shortens the refrigerated haul into retail distribution centres, which matters because fresh mushrooms are perishable and heavy relative to their value. Annual capacity is about 130,000 tonnes, and the group operates in 2 countries, the United States and Mexico, with roughly 2,000 employees after the reorganisation completed in 2025.

Sales go overwhelmingly into the fresh mushroom category, which represents about 98 per cent of revenue, and reach mainstream North American supermarket chains and food-service distributors, with the balance coming from compost and related products. Because mushrooms are sold as a fresh commodity, retail programmes are won on price, supply reliability and pack format rather than on brand preference. That makes the vitamin D lines and organic certification the main routes to a premium, and the compost business a way to recover value from material that would otherwise be a disposal cost.

The assessment has to weigh a strong franchise against a hard restructuring. In late 2025 and early 2026 the company arranged a US$22 million senior secured credit facility with Gibraltar Business Capital to automate and modernise its farms, and it released a certified organic spent mushroom compost to California farmers, both of which point to a business investing to defend its position. But it also closed its 275-acre Royal Oaks farm in California and laid off 605 workers, shifting that volume to Morgan Hill and to farms in other states, a decision attributed to ageing facilities and to high regulatory and labour costs in the state.

Unlisted

Founded

1971

Workforce

2,000

Facilities

7 production sites and distribution centres (California, Texas, Pennsylvania, Illinois, Mexico)

Presence

2 countries (United States, Mexico)

HQ

United States

Type

Brand

Market

Unlisted

Agricultural ProductsAgricultural Products BrandsAgricultural Products Suppliers

Hokuto Corporation, which sells under the brand HOKTO, is a Japanese manufacturer of cultivated mushrooms and of the equipment and packaging used to grow them. Founded on 22 July 1964 and headquartered in Nagano City, Nagano Prefecture, it pioneered factory-style mushroom production in Japan: rather than growing outdoors or in sheds, it raises buna-shimeji, maitake, king oyster and white shimeji mushrooms in climate-controlled rooms fed by a bottling line. It is listed on the Tokyo Stock Exchange Prime Market under code 1379. Hokuto Corporation is not a Fortune Global 500 company; forecast revenue of about US$480 million for the 2025/2026 fiscal year is far below the threshold used for the 2025 list.

The company began in 1964 in Nagano Prefecture, a mountainous region with a long foraging tradition for wild mushrooms and little flat farmland, which made controlled indoor cultivation an attractive proposition. Hokuto industrialised the process by standardising substrate, sterilisation and climate control, so output no longer depended on season or weather, and it grew by adding production centres across Japan. Overseas plants in the United States, Taiwan and Malaysia followed, carrying the same cultivation model into markets where the company had no prior retail presence.

The product range is built on four commercial species: buna-shimeji, marketed internationally as the signature HOKTO mushroom, maitake, king oyster and white shimeji. All are sold fresh to supermarkets and food-service customers, mostly in small retail packs, with a smaller processed range. Alongside the food business, the company manufactures agricultural packaging materials and cultivation machinery, which supplies around 12 per cent of revenue and equips both its own plants and other growers. The combination is unusual on this page: Hokuto sells the crop and the industrial means of producing it.

Manufacturing is organised through 19 production centres, including 32 plants in Japan and overseas bases in the United States, Taiwan and Malaysia, with annual capacity of about 75,000 tonnes of buna-shimeji, king oyster and maitake. Cultivation is highly automated: substrate is prepared and inoculated under controlled conditions, rooms run on close environmental control, and harvesting is increasingly supported by machines. Research effort goes into gene breeding and into AI-driven picking robots, the two areas where the company expects further reductions in unit labour cost.

The group operates in 5 countries and regions, led by Japan, where its brand has high retail recognition, with the United States and Southeast Asian markets growing fastest. Forecast revenue for the fiscal year ending in 2026 is JPY 72.5 billion, about US$480 million, of which roughly 88 per cent comes from edible mushrooms and the remainder from agricultural packaging and machinery. About 4,100 people are employed across the network, and the first quarter of the 2025/2026 year was described as solid, with overseas growth the most visible contributor.

The assessment is favourable on technology and disclosure: as a Prime Market listed company, Hokuto reports quarterly and scores well on capital transparency, and its automated model shields it from the labour-cost pressure that has forced farm closures in North America. The near-term risk is domestic cost. Electricity and energy prices in Japan are high, and the woodchips imported for growing substrate have become more expensive, both of which bear directly on a factory model whose largest variable costs are energy and medium. Those pressures are expected to compress profitability in the Japanese business over the short term.

Founded

1964

Workforce

4,100

Facilities

19 production centres; 32 plants in Japan plus US, Taiwan and Malaysia sites

Presence

5 countries and regions (Japan, USA, Malaysia, Taiwan, others)

HQ

Japan

Market cap

$427 M

Agricultural ProductsAgricultural Products BrandsAgricultural Products Suppliers

Shanghai Snowey Bio-Technology Co., Ltd. is a Chinese industrialised mushroom producer trading under the brand Snowey. Founded in 1997 and based in the modern agriculture park of Fengxian District, Shanghai, it grows enoki, shimeji, white shimeji, crab-flavour shimeji and king oyster mushrooms under factory conditions rather than in open fields, and sells them fresh across China and into several Asian markets. It is listed on the ChiNext board of the Shenzhen Stock Exchange under code 300511. Shanghai Snowey Bio-Technology is not a Fortune Global 500 company; revenue of about US$360 million in 2025 is a small fraction of the threshold used for the 2025 list.

The company was founded in 1997, when Chinese mushroom production was still dominated by seasonal, labour-intensive methods. Its proposition was to move the crop into climate-controlled factories where temperature, humidity and carbon dioxide can be held constant, so that enoki and shimeji could be produced to a schedule all year and sold in standardised packs. That model was then replicated geographically: bases were added in Jilin, Shandong, Guangdong, Gansu and Sichuan, and later in Thailand, spreading production across different climates and closer to consumption centres.

The fresh range is dominated by enoki and hypsizygus types. Enoki is the volume leader, supported by brown and white shimeji, crab-flavour shimeji and king oyster. All are grown in bottles or bags on prepared substrate, harvested in a single cut and packed for retail, food-service and wholesale channels. A smaller deep-processing business turns part of the crop into prepared products, which normally carries better margins than fresh sales but competes for the same raw material when farm-gate prices are high.

Production is concentrated in 18 modern industrialised bases. Daily capacity exceeds 1,350 tonnes and annual capacity is about 480,000 tonnes, with enoki and shimeji the main contributors. Because every base runs on full factory environmental control, output does not vary with the season and quality is consistent enough for supermarket specification work. Distribution runs through a cold-chain network covering the country's main hubs, combining the company's own logistics assets with third-party carriers, which is the practical way to reach national retail coverage from bases spread across six provinces plus Thailand.

Snowey sells in 3 countries, mainly China, with Thailand and Vietnam serving Southeast Asian demand, and it is among the largest industrialised mushroom producers in the country by daily output. Revenue reached about RMB 2.55 billion in 2025, roughly US$360 million, of which edible mushrooms accounted for about 96 per cent. About 4,500 people work for the group. The scale of the base network is what allows the company to hold volume contracts, but it also means that profitability is driven by industry-wide capacity and pricing rather than by any single product.

Financially, 2025 was a turnaround year. A profit forecast for the period indicated net profit attributable to shareholders of RMB 29 million to RMB 40 million, against a loss of RMB 617 million in the prior year, as surplus capacity in the industry was absorbed and mushroom selling prices stabilised. The recovery is real but thin relative to the asset base: the business carries heavy depreciation on its production facilities, and some regional markets remain exposed to short-term structural swings in supply and demand. A company with 480,000 tonnes of annual capacity has limited room to cut output when prices fall.

Founded

1997

Workforce

4,500

Facilities

18 industrialised production bases (Shanghai, Jilin, Shandong, Guangdong, Gansu, Sichuan, Thailand)

Presence

3 countries (China, Thailand, Vietnam and others)

HQ

China

Market cap

$369 M

Agricultural ProductsAgricultural Products BrandsAgricultural Products Suppliers

Gansu Zongxing Mushroom Technology Co., Ltd. is a Chinese industrialised grower of enoki and button mushrooms, trading under the brand Zongxing Mushroom. Founded in 2005 and headquartered in the national agricultural science and technology park in Tianshui, Gansu Province, it grows both crops in climate-controlled rooms, formulates its own substrate and runs its own spawn breeding, and sells fresh mushrooms across China. It is listed on the main board of the Shenzhen Stock Exchange under code 002772. Gansu Zongxing Mushroom Technology is not a Fortune Global 500 company; revenue of about US$295 million in 2025 is far below the threshold used for the 2025 list.

The company was established in 2005 in Gansu, a north-western province where cool conditions and cheap land made industrialised cultivation viable, and it began with enoki mushrooms grown in bottles in insulated rooms. The second crop, the agaricus button mushroom, was added later and is produced on a composting rather than a bottle system, so the company now runs two different technologies side by side. Expansion since then has been geographic: bases were built in Shaanxi, Shandong, Jiangsu, Sichuan and Anhui, and a joint venture project took the business outside China for the first time, to Poland.

The fresh product range is narrow and deliberate. Enoki is the larger line, sold in consumer packs and in bulk for food service and hotpot-style catering, and button mushrooms form the second pillar, supplying the retail and processing markets that Western-style mushrooms serve in China. Spawn and strain breeding sit upstream and are treated as a business in their own right. The company also formulates its own growing substrate from liquid spawn fermentation onwards, which keeps the two most failure-prone steps of industrialised cultivation, the culture and the medium, inside the company.

Production runs through 16 modern production bases. Annual capacity exceeds 360,000 tonnes, with button mushrooms at roughly 300 tonnes a day and enoki above 700 tonnes a day. Rooms are intelligently controlled and the process from substrate mixing to harvest is scheduled rather than seasonal, so output is stable through the year and quality is repeatable enough for supermarket programmes. Because the bases are distributed across six provinces, freight distances to the main consumption regions are shorter than they would be from a single mega-site, but each location carries its own fixed overhead.

Revenue for 2025 was RMB 2.098 billion, about US$295 million, up 8.43 per cent year on year, with net profit attributable to shareholders of RMB 335 million. Edible mushrooms account for about 99 per cent of sales, the purest category focus on this page. The company operates in 2 countries, China and the Poland joint venture project, and employed about 3,800 people. Trading held up into 2026, with first-half revenue of RMB 1.085 billion, suggesting that the cost and utilisation advantages behind the 2025 result persisted into the following period.

The financial performance is the strongest of the Chinese producers here: a company that earned RMB 335 million in 2025 while a larger domestic rival was recovering from a loss of RMB 617 million, and it did so on roughly a third of that rival's revenue. The risks are execution and price. Some new production lines have had their construction schedules adjusted slightly by local planning requirements, so the timing of capacity additions is not entirely within the company's control, and both of its crops are commodities whose prices move with national supply. A grower with 99 per cent of revenue in mushrooms has no other business to absorb a price trough.

Founded

2005

Workforce

3,800

Facilities

16 production bases (Gansu, Shaanxi, Shandong, Jiangsu, Sichuan, Anhui)

Presence

2 countries (China; Poland joint venture project)

HQ

China

Market cap

$410 M

Agricultural ProductsAgricultural Products BrandsAgricultural Products Suppliers

Costa Group Holdings Pty Ltd is an Australian horticultural grower, packer and marketer of fresh produce that trades under the brand Costa, with consumer labels including MushBoom, Perino and Lovacado. Its business support centre is at Level 5, 818 Bourke Street, Docklands, VIC 3008, Australia; the long-standing registered and principal address up to August 2023 was 275 Robinsons Road, Ravenhall, VIC 3023. Costa Group is not a Fortune Global 500 company. It has been privately held since February 2024 and its last public full-year revenue, A$1,458.55 million for FY2023, is far below Fortune Global 500 scale; no consortium member's size is Costa's own size.

The business traces to a family produce operation in the late 1800s. Company history dates its origins to 1895, when Francesco Costa arrived in Australia from Salina, Italy, and the February 2024 take-private announcement describes a company started by the Costa family in Geelong, Victoria with a more than 120-year history. The founding year of 1888 that appears in third-party reference material such as Wikipedia has no company source. The listed entity, ACN 151 363 129, was registered on 29 June 2011, floated on the ASX in July 2015 and was renamed Costa Group Holdings Pty Ltd on 3 June 2024 after the take-private.

FY2023, the year ended 31 December 2023, produced revenue of A$1,458.55 million, sales of A$1,420.73 million and a net loss of A$24.32 million, against FY2022 revenue of A$1,357.56 million and net income of A$33.63 million. The last half-year disclosure, the 26 weeks ended 2 July 2023, reported revenue of A$770.7 million, up 8.7%, EBITDA-S of A$150.2 million, NPAT-S of A$37.8 million and net debt of A$350.1 million at 2.31x leverage. No FY2024 or FY2025 results exist publicly: Costa was taken private in February 2024 and no longer files financial statements.

Production spans four countries. In Australia the group runs mushroom farms at Monarto in South Australia, Mernda in Victoria and Casuarina in Western Australia; glasshouses at Guyra in New South Wales; citrus farms and packhouses including Kangara at Murtho and Yandilla at Renmark; berry farms in four states with a packhouse and distribution centre at East Devonport; a banana farm at Walkamin; and avocado farms at Comboyne, Fishermans Reach and four Queensland sites. Berry International operates nine growing sites in Yunnan, China, farms at Larache and six further Moroccan locations, and a new operation at Paksong in Laos. Total cropping area is 8,532 hectares, of which 2,565 hectares, or 30%, is protected, and the 2025 workforce was 11,156 FTE direct hires.

Ownership is a consortium structure. Costa was acquired by Chilli Buyer Pty Ltd, a bidco for a consortium led by Paine Schwartz Partners with Driscoll's, Inc. and British Columbia Investment Management Corporation, at A$3.20 cash per share, an equity value of about A$1,496 million and an enterprise value of about A$2,459 million; Paine Schwartz and Driscoll's affiliates held about 19.62% of the shares before the scheme. Driscoll's is a minority co-investor and long-standing berry joint-venture partner, not the acquirer. On category claims: Australia's largest citrus grower and Australia's leading mushroom grower are company statements, but for berries its website says only that it is one of Australia's leading berry producers. Stone fruit is not a disclosed core category, and no country count or facility count is published.

Unlisted

Founded

1895

Workforce

11,156

Facilities

Mushroom farms Monarto SA, Mernda VIC, Casuarina WA; glasshouse Guyra NSW; citrus Murtho & Renmark SA; berry packhouse TAS; China (Yunnan) nine sites; 8,532 ha cropping

Presence

Australia plus China (Yunnan), Morocco, Laos; varieties licensed in the Americas, Africa

HQ

Australia

Type

Brand

Market

Unlisted

Agricultural ProductsAgricultural Products BrandsAgricultural Products Suppliers
7South Mill Champs LLC

South Mill Champs LLC is an American grower, packer and processor of mushrooms sold under the South Mill Champs and Champs Mushrooms names. It is based in Kennett Square, Chester County, Pennsylvania, the town that has anchored the United States mushroom industry for more than a century, and it also operates in Canada. Its origins are dated to 1932; the present company was formed in 2017 when South Mill and Champs Mushrooms merged. It is privately held and controlled by the private equity investors Sun Valley Investments and EoP Holdings. South Mill Champs LLC is not a Fortune Global 500 company: revenue of approximately US$380 million in 2025 is a little over one per cent of the approximately US$32.2 billion threshold applied for the 2025 list, and no investor in the group is a member of it.

Revenue for 2025 was approximately US$380 million, of which mushrooms and mushroom-derived products account for about 95%. That is a pure mix by the standards of the food industry, and it leaves little room to absorb a mushroom-specific downturn with earnings from elsewhere. The group employs about 2,200 people across its two countries, and annual production exceeds 85,000 tonnes; the western Canadian business alone produces more than 18,000 tonnes, or roughly 40 million pounds, a year. Those figures place South Mill Champs behind Monterey Mushrooms in North America, and the gap is structural rather than cyclical.

The two names in the company's history came from separate mushroom businesses in the same Pennsylvania region, and their 2017 combination brought compost preparation, growing, packing and refrigerated distribution under a single owner. The Champs Mushrooms identity survived the merger and remains in use on the group's farm operations, while South Mill Champs serves as the corporate brand. The 1932 founding date used on this page refers to the older of the two predecessors rather than to the merger itself.

Fresh mushrooms remain the core of the range: white, brown and speciality varieties grown in climate-controlled rooms and sold through retail and foodservice channels. Growth, however, is in processed formats. Frozen mushrooms, dried mushrooms and the Shrooms snack range move the business away from the fresh price cycle, in which a single week of oversupply can reset retail prices for a season, and towards products with longer shelf lives and steadier margins. Prepared frozen mushroom packs, designed for cooking rather than for the produce aisle, are the clearest expression of that shift.

Growing and processing take place at seven large sites in Pennsylvania and British Columbia. Two countries is a narrow footprint next to the global networks of the European leaders on this page, and it is deliberate: the Pennsylvania base sits in the densest part of the United States mushroom market, while the Canadian operation serves western Canada and is the largest producer in that region. Compost is prepared in-house, growing rooms are climate-controlled, and the group runs its own refrigerated transport between farms, packing houses and distribution centres.

The pressure point is the border. South Mill Champs moves compost, fresh mushrooms and frozen product between the United States and Canada, and cross-border freight has become materially more expensive. For a perishable crop that is heavy and low in value per kilogram, transport is a first-order cost rather than a rounding error, and higher charges cannot simply be passed through in retail contracts. The company's answer has been distribution: in 2025 the Shrooms snack brand and prepared frozen mushroom packs extended their coverage in mainstream North American supermarkets, including Walmart and Costco.

Private

Founded

1932

Workforce

2,200

Facilities

7 growing sites and processing plants in Pennsylvania and British Columbia

Presence

2 countries: United States and Canada

HQ

United States

Type

Brand

Market

Private

Agricultural ProductsAgricultural Products BrandsEdible Mushrooms Brands

Yukiguni Maitake Co., Ltd. is a Japanese cultivator and processor of speciality mushrooms that sells under the consumer brand Yukiguni Maitake. Its head office is in Minamiuonuma, Niigata Prefecture, the snow-country district that gave the company its name and where most of its growing capacity still sits. The business was founded in 1983 and is listed on the Prime Market of the Tokyo Stock Exchange under the code 1375, one of four exchange-listed growers among the ten companies on this page. Yukiguni Maitake Co., Ltd. is not a Fortune Global 500 company: revenue of about JPY 48.2 billion, or roughly US$320 million, in the 2025/2026 financial year is about one per cent of the approximately US$32.2 billion threshold applied for the 2025 list, and no shareholder of the company is a member of it.

The company's identity rests on a single species. Maitake is harder to fruit indoors at industrial scale than button mushrooms or enoki, and sterile artificial cultivation technology for the species is what turned Yukiguni Maitake from a regional grower into the leading supplier of maitake in Japan. That technical lead is also why the species still commands a premium at retail, and why the company's margins have depended more on mix than on volume. King oyster and brown beech mushrooms and processed health-food products widen the base, but the premium still rests on maitake.

Revenue for the 2025/2026 financial year is JPY 48.2 billion, approximately US$320 million, of which mushrooms account for about 94% and processed food lines for the remainder. Output runs at around 55,000 tonnes a year from eleven modern fruiting and processing plants, most of them in and around Niigata Prefecture. About 1,150 people are employed across the group, small against the tonnage, reflecting heavily automated growing rooms. The company reports operations in three countries and regions, Japan dominant among them, and sells roughly 45% of its non-maitake mushroom lines overseas.

Founded in 1983 in a region whose cold winters and clean water suit controlled cultivation, the company grew from a local producer into a national supplier and then into a listed business. It has kept cultivation and processing close together in Niigata rather than dispersing them across contract farms, which is expensive to build and slow to copy, and that is why the position has proved defensible. The same choice leaves the group carrying Japanese energy, materials and labour costs in full, with no low-cost offshore base to offset them.

Trading in the 2025/2026 year has been about price rather than volume. Shipping prices for the company's mushrooms stabilised and then began to recover in the second quarter, and management has worked the retail side of the business by promoting small, high-freshness packs and a wider range of cooking suggestions, including promotional partnerships with social media influencers. Those measures raise the value of a fixed harvest rather than requiring a larger one. Investment continues in automation, sterile cultivation research and processed health-food lines built on maitake extracts.

Cost inflation is the immediate problem. Sawdust and nutrient substrates are largely bought in, freight charges have risen, and together they have pressed core EBITDA year on year; the company has responded with manufacturing cost reduction and flexible control of production volumes rather than with price increases that a price-sensitive domestic market may not accept. The longer-term exposure is the premium itself: if maitake loses its speciality status, or if larger commodity growers replicate sterile cultivation and add capacity, the pricing advantage that supports the whole position narrows.

Founded

1983

Workforce

1,150

Facilities

11 fruiting and processing plants, mainly in Niigata Prefecture

Presence

3 countries and regions; Japan dominant

HQ

Japan

Market cap

$286 M

Agricultural ProductsAgricultural Products BrandsAgricultural Products Suppliers
9OKECHAMP S.A.

OKECHAMP S.A. is a Polish cultivator and processor of mushrooms that sells fresh produce under its corporate brand and processed mushrooms under the retail brand OLE!. It is registered in Poznan in the Greater Poland Voivodeship, with production concentrated at Grodzisk Wielkopolski and Borucino. The company was founded in 1992 and remains privately held as a joint-stock company with no shares admitted to trading. OKECHAMP S.A. is not a Fortune Global 500 company: revenue of approximately US$210 million in 2025 is less than one per cent of the approximately US$32.2 billion threshold applied for the 2025 list, and no shareholder behind the company is a member of it.

What distinguishes the business from most of the names on this page is that processing is not a sideline. Fresh mushrooms are grown and sold, but the stronger position is in canned mushrooms, frozen mushrooms and prepared vegetable specialities, where OKECHAMP is one of the larger processors in Europe. The difference is commercial: canned and jarred mushrooms can be stored for months, shipped without refrigeration and sold year-round, which converts a perishable crop into an ambient food product with a much longer reach. Mushroom-derived products account for about 85% of revenue, with vegetable specialities made on shared lines accounting for the balance.

Revenue for 2025 was approximately US$210 million, and processing capacity exceeds 65,000 tonnes of mushrooms a year. The assets behind that figure are three large plants and compost substrate centres at Grodzisk Wielkopolski and Borucino, worked by roughly 1,000 people. Products reach customers in twelve countries and regions, chiefly Poland, the Netherlands, Germany and France. The company runs two commercial channels side by side: own-brand and private-label goods for retailers, and contract processing for other food businesses, a structure that steadies factory loading but leaves part of the pricing with the customer.

Vertical integration is the operating logic. Compost substrate is prepared at the group's own centres, mushrooms are grown in controlled houses, and the harvest moves into canning, freezing and glass-jarring lines at the same locations before it is distributed across Europe. Owning both growing and processing is what allows each crop to be graded into fresh, canned and frozen streams according to quality and prevailing market price, instead of selling whatever the fresh market will take on the day of picking. Preparing compost in-house also puts the largest single input cost under the group's own control.

Growth through 2025 and 2026 has concentrated on the higher-value end of the processed range. The company has widened exports of organic canned mushrooms and glass-jarred products, aiming at premium retail channels in Western Europe and North America. Organic certification and glass packaging sell to buyers who pay for provenance rather than volume, and both formats travel well, so the expansion is commercial rather than industrial. The dual-track model adds resilience at the same time: when fresh prices fall, more of the harvest can be diverted into the processing lines.

Two pressures shape the outlook. European environmental regulation is tightening around agricultural waste, packaging and emissions, and compliance weighs hardest on processors that run large fixed sites and ambient packaging lines. Polish labour costs, meanwhile, have risen steadily as the economy converges with Western Europe, eroding the wage advantage that made Poland a processing base for German and Dutch retail. Neither trend reverses quickly, and both arrive at a company whose margins depend on running high volumes through three plants.

Private

Founded

1992

Workforce

1,000

Facilities

3 large plants and compost substrate centres at Grodzisk Wielkopolski and Borucino

Presence

12 countries and regions; Poland, Netherlands, Germany, France

HQ

Poland

Type

Brand

Market

Private

Agricultural ProductsAgricultural Products BrandsEdible Mushrooms Brands

Shanghai Finc Bio-Tech Inc. is a Chinese industrial cultivator of speciality mushrooms that sells under the brand Finc. Its head office is in the Minhang District of Shanghai, and production is spread across five intelligent industrial bases elsewhere in the country. The company was founded in 2001 and is not listed today: after a period on China's New Third Board it was restructured into a privately held high-technology agricultural business. Shanghai Finc Bio-Tech Inc. is not a Fortune Global 500 company: revenue of approximately RMB 1.15 billion, or about US$160 million, in 2025 is roughly half a per cent of the approximately US$32.2 billion threshold applied for the 2025 list, and no shareholder of the company is a member of it.

The company specialises in the small cluster mushrooms that Western retailers sell as white and brown shimeji, together with maitake and deer-horn mushroom. These are not the commodity varieties that dominate Chinese mushroom output by tonnage; they are grown to narrower specifications for buyers who care about size, colour and shelf life, and Finc was among the first Chinese producers to grow the white and brown types industrially. Cultivation in bottles and bags in climate-controlled rooms puts the crop on a fixed cycle, so output does not depend on weather and quality is repeatable enough for overseas supermarket specifications.

Revenue for 2025 was approximately RMB 1.15 billion, or about US$160 million, with mushrooms accounting for roughly 98% of the total, among the purest mixes on this page. About 1,800 people work across the group's cultivation, packing and export functions. Five intelligent production bases, including sites in Shanghai, Qingdao and Qiqihar, give capacity above 120,000 tonnes a year, and the provincial spread means output is not tied to one climate zone or one labour pool. Several of the northern sites shorten the overland leg to export gateways.

Exports are the distinguishing feature of the business. Finc's mushrooms reach more than thirty countries and regions, among them the United States, the European Union, Japan and South-East Asia, and its white and brown shimeji are stocked by mainstream overseas chains including H-Mart and Whole Foods. Selling into those channels requires certified food-safety systems, refrigeration from growing room to container and packaging that survives long sea transit, all of which the company reports as internal capabilities. Organic-certified lines are a rising share of the export book.

China's industrial mushroom sector is the largest in the world and also the most competitive, and Finc competes in its speciality tier rather than its commodity tier. That distinction is the investment case: enoki and oyster mushrooms are produced by very large factories on thin margins, while shimeji and maitake for export carry specifications that narrow the field of acceptable suppliers and support better prices. Its spending has therefore gone into automation and export-grade quality control rather than volume capacity that would put it against the commodity producers.

The exposure is at home. Price competition in China's commodity mushroom market has spread into the middle of the supply chain, and even a speciality grower feels it when buyers trade down to cheaper varieties or when oversupply depresses prices across the category. Finc's defence is its export share, where prices are better and contracts longer, but that leaves the business exposed to trade policy, container freight rates and foreign retail listings it does not control. With five production bases and no public reporting since it left the New Third Board, its margins cannot be judged from outside.

Private

Founded

2001

Workforce

1,800

Facilities

5 intelligent industrial cultivation bases: Shanghai, Qingdao, Qiqihar and others

Presence

Exports and sales to 30-plus countries and regions

HQ

China

Type

Brand

Market

Private

Agricultural ProductsAgricultural Products BrandsEdible Mushrooms Brands

Frequently Asked Questions

05
How Do You Grow A Mushroom In A Building Rather Than A Field, And What Does That Change About Cost And Output?

A cultivated mushroom is grown inside a building, on substrate manufactured for the purpose, so the unit of production is a room rather than a hectare and the capacity figure that matters is tonnes per day. That single fact explains why this category is ranked differently from vegetables or fruit. Weather is priced out of the growing cycle and replaced by electricity, sterilisation, spawn quality and the cost of holding a room at a fixed temperature and carbon dioxide level. What a grower controls is the schedule: substrates are prepared in batches, inoculated with liquid spawn, fruited on a fixed cycle and cleared for the next crop, so output is adjusted by deciding how many rooms are running. It also explains why the companies here quote tonnage. Shanghai Snowey Bio-Technology runs 18 industrialised bases and more than 1,350 tonnes a day, about 480,000 tonnes a year, and Gansu Zongxing runs 16 bases and over 360,000 tonnes a year, of which button mushrooms account for around 300 tonnes a day and enoki more than 700.

The substrate is an engineered input, and the recipe is part of the competitive position. Composted straw, poultry litter, sawdust and bran are mixed, pasteurised and packed into beds, bags or bottles, and the mix decides which species will fruit and how much can be taken from each square metre of room. A company that formulates its own substrate and breeds its own spawn controls two costs that a grower buying compost and spawn on the open market cannot, which is why Gansu Zongxing describes liquid fermentation of spawn and substrate formulation as part of its own chain. It is also why the index gives 15% to supply-chain control and production base scale, measured on owned growing rooms, compost and substrate plants, daily and annual capacity, countries of operation and automation rather than on contracted volume.

Three different answers to the same engineering problem are visible in the numbers. Hokuto Corporation runs 19 production centres across five countries and regions behind about 75,000 tonnes a year, Yukiguni Maitake grows about 55,000 tonnes from 11 plants in Niigata with its weight in maitake, and Monaghan Mushrooms covers 12 vertically integrated farms and compost plants across six countries with more than 200,000 tonnes. Monterey Mushroom Holdings works seven sites for about 130,000 tonnes, South Mill Champs more than 85,000 tonnes, OKECHAMP over 65,000 tonnes from three plants, and Costa Group Holdings about 45,000 tonnes from six farms. One crop, one building type, very different asset footprints.

Ownership of the building is what decides whether the model is defensible. A room-based grower has to fund the rooms before it sells a single mushroom, so the balance sheet carries buildings, climate plant, bottling lines and cold storage, and depreciation runs whether the crop is good or bad. Snowey carried a loss of RMB 617 million in 2024 on that cost base before forecasting a return to profit of RMB 29 million to 40 million for 2025, and its depreciation remains heavy. Capacity should therefore be read next to utilisation, not as a proxy for profit.

The factory model removes weather risk but concentrates energy and input risk. Hokuto faces Japanese electricity prices and imported woodchip costs, Yukiguni Maitake faces substrate and freight costs that have compressed its core EBITDA, and Costa Group Holdings absorbs Australian electricity prices and drought or flood risk across its sites. Nothing in the model is free: a room pays only if power, substrate and cold chain stay cheap relative to the price of a punnet, and that relationship is what the index's weightings on sales scale and purity are meant to capture.

Why Is The Cost Of A Picking Hand Reorganising Global Mushroom Production, And Which Companies Are Hedging It?

The cost of a picking hand and the price of a kilowatt hour now decide where mushrooms come from, and the ten companies on this page sit on opposite sides of that trade. Mushroom picking is one of the least mechanisable jobs in fresh produce: the fruit is fragile, it comes in flushes, and the window between a marketable mushroom and an unsellable one is measured in hours. That is why the closure of Monterey Mushroom Holdings' Royal Oaks farm in California, 275 acres and 605 workers, matters beyond its size. The company moved that volume to Morgan Hill and to farms in other states after also shutting sites in Illinois and Florida, and took a US$22 million senior secured facility earmarked for automation; about 2,000 people work there today. When a wage bill reaches the point where a farm cannot be run at the price retailers will pay, the volume travels and the price does not.

The alternative to moving is automating, and that has been the East Asian route. Hokuto Corporation spends on AI picking robots and on breeding, and Shanghai Snowey Bio-Technology and Gansu Zongxing keep building climate-controlled rooms fed by liquid spawn and sorted by machine; companies working this way have cut the labour needed per tonne of mushrooms by more than 70%. The saving is not only wages. Fewer hands in a cold, wet room means fewer injury and compliance problems, which is why capital goes into rooms, robots and vision systems instead of into recruitment. Hokuto works 19 production centres, Snowey runs 18 industrialised bases at more than 1,350 tonnes a day, and Zongxing runs 16 bases and over 360,000 tonnes a year.

Europe is not exempt, because regulation and wages arrive together. OKECHAMP S.A. faces tightening European environmental rules alongside Polish wages that no longer look cheap in the way they did when its three plants were built, while Monaghan Mushrooms, the largest business on this page at about US$1.15 billion of revenue for 2025, is squeezed by British and European labour costs and by volatile straw and poultry-litter prices at the same time. Costa Group Holdings absorbs Australian electricity prices and drought or flood risk. Three geographies, one shared problem: the input side of the room is getting more expensive faster than retail prices are rising.

Geography follows the cost curves, which is why this list is a three-way comparison rather than a single league table. Japan sells technique and premium species, China sells scale and cost, and Europe and North America sell agaricus at industrial scale with compost, logistics and certification attached. The division shows in the assets: Hokuto runs 19 production centres across five countries and regions, Yukiguni Maitake grows about 55,000 tonnes from 11 plants, Monaghan owns 12 farms and compost plants across six countries, South Mill Champs works seven sites on more than 85,000 tonnes, and Costa works six farms in Australia.

What to check before accepting any automation claim. Ask whether the robots and the rooms are owned or leased, whether the headcount quoted is measured before or after a restructuring, whether a closed site has been replaced by capacity elsewhere or simply dropped, and whether the saving appears in margin or only in a press release. Monterey's facility is a credit line for modernisation rather than evidence of a finished programme, and Snowey reports revenue growth while still carrying heavy depreciation, which means its automation has not yet been proved to pay for itself.

What Does Mushroom Revenue Purity Measure, And Why Does A Diversified Group Have To Be Read Differently?

Purity is the share of a company's revenue that comes from mushrooms, and on this page it decides whether one number can be compared with the next at all. The index gives purity a 25% weight because this category is unusually easy to contaminate with unrelated business: a mushroom grower can sell packaged snacks, canned vegetables, farm machinery or horticultural services from the same balance sheet, and the resulting turnover tells a reader very little about the mushroom business underneath. The disclosed ladder runs from near-total focus to a minority share. Gansu Zongxing draws about 99% of its revenue from mushrooms, Monterey Mushroom Holdings about 98%, Shanghai Finc Bio-Tech about 98%, Snowey about 96%, Monaghan Mushrooms about 95% and South Mill Champs about 95%, Yukiguni Maitake about 94%, Hokuto about 88% with the balance in agricultural packaging and machinery, and OKECHAMP about 85% once its canned and frozen vegetable lines are counted.

Costa Group Holdings shows why the denominator matters more than the label. Its mushroom division is entirely mushrooms, yet it supplies roughly a fifth of group revenue, so its US$280 million is a divisional figure and not a company figure. Set beside a stand-alone grower reporting about US$160 million or about US$360 million, that number reads differently depending on what sits above it, and anyone who treats division revenue as brand revenue will draw the wrong conclusion about scale. The workable comparison is division against division or company against company, never one against the other, and a group figure should never be attributed to the mushroom brand inside it.

High purity describes focus; it does not certify health. Shanghai Finc Bio-Tech reports about 98% purity while facing a domestic price war for commodity mushrooms and publishing no accounts, Gansu Zongxing reports about 99% purity while local planning decisions have shifted the timetable for new production lines, and Snowey reports about 96% purity immediately after a loss of RMB 617 million in 2024. Concentration protects a company from being misread by an analyst; it does not protect it from the commodity cycle in button mushrooms or enoki, and the two risks should be kept apart.

Diversification is not automatically a discount either. Hokuto's remaining 12% comes from the packaging and machinery used to grow mushrooms, which supports the growing business rather than competing with it, and OKECHAMP's processed lines take its own crop into jars and freezers, which is a way of selling the same mushrooms at a better price. What the purity weight penalises is unrelated revenue: turnover arriving from another crop or another industry that makes a mushroom brand look larger than its mushroom business is, and that is the distinction a reader should apply before crediting any diversification story.

How to use the purity figure when comparing two companies. Ask for the disclosed split rather than inferring it from the product range, establish whether the percentage is measured against group or divisional revenue, check whether the split has moved across the last two reporting years, and read the number next to capacity and utilisation. A company at 95% purity with half-empty rooms and a company at 88% purity with sold-out rooms at premium prices are not the same business, and the index is built to treat them differently.

Why Do Four Mushroom Growers List In Tokyo Or Shenzhen While Six Stay Private, And What Should A Buyer Take From That Split?

Four of the ten publish audited accounts and all four list in Tokyo or Shenzhen, which makes this page a study in two disclosure regimes rather than one. Hokuto Corporation trades on the Tokyo Stock Exchange Prime Market under 1379, Yukiguni Maitake on the same market under 1375, Shanghai Snowey Bio-Technology on the ChiNext board of the Shenzhen Stock Exchange under 300511 and Gansu Zongxing on the Shenzhen main board under 002772. Between them they publish revenue, purity splits, capacity, plant counts and, in the two Japanese cases, quarterly progress against forecast. That is why most of the hard numbers here come from those four names: Yukiguni's second-quarter disclosure for the year ending March 2026, Snowey's 2025 earnings forecast, and Zongxing's 2025 revenue of RMB 2.098 billion, up 8.43% year on year.

The other six carry no obligation to publish and mostly take advantage of that. Monaghan Mushrooms is family controlled, Monterey Mushroom Holdings is privately held, South Mill Champs is controlled by private equity, OKECHAMP is a joint-stock company with no shares admitted to trading, Shanghai Finc Bio-Tech left China's New Third Board and now files no accounts, and Costa Group Holdings was taken private by an investor consortium. A private owner can run identical assets and take identical decisions while publishing nothing, and that is precisely what most of the six do. The information does not vanish when a company goes private; it stops arriving on a schedule, which is a different kind of problem for anyone trying to compare years.

Physical facts are harder to hide than financial ones, and they carry the analysis. Farms, growing rooms, compost plants, distribution centres and country counts can be counted and checked against company statements, capacity in tonnes can be set against a competitor's, and certifications such as Monterey's organically certified compost are matters of record. Financing leaves traces as well: the US$22 million senior secured facility Monterey took for automation had to be announced by the lender. A reader can therefore establish what a private company owns and roughly how much it grows, even when nothing establishes what it earns.

Estimates must be handled as estimates, with the estimator named. Revenue figures for the six private companies are approximations rather than audited outcomes, and they are quoted as such. They should never be used to infer membership in the Fortune Global 500, a list VerityRank tests directly: none of the ten is a Fortune Global 500 member. No entrant is credited with the scale of an investor, a licensor or a joint-venture partner. Costa's consortium ownership illustrates the trap perfectly, because the institutions that bought it are large and that says nothing whatever about the size of the mushroom business they acquired.

Why the split matters for the ranking itself. A page that can audit only four of its ten entries has to be explicit about which claims rest on filings and which rest on company statements and named reporting. The 10% weight on capital transparency and ESG exists for that reason: an exchange-listed grower reporting quarterly scores differently from a family company of the same size that publishes nothing, and a reader is entitled to know which figure came from where before comparing the two.

Why Has Spent Mushroom Substrate Become A Product, And How Does It Decide Access To Premium Retail?

Spent substrate used to be the largest waste line in a mushroom business and is now a product, a fuel source and a condition of access to the best-paying retailers. Every tonne of mushrooms leaves a far larger mass of exhausted substrate behind it, and for decades that material was a disposal problem with a cost attached. The companies on this page have moved in three directions at once: selling it as compost, burning it for energy and redesigning the packaging around it. What connects the three is that European and North American rules on carbon footprints and agricultural waste have turned disposal practice into a gate rather than an expense line, so a grower that cannot document what happens to its residue struggles to sell to the chains that pay best.

Monterey Mushroom Holdings turned the pile into a certified input for other farmers. The company markets an organically certified compost made from material that has already fruited to growers in California, which converts a waste-handling cost into a sale, and it took a US$22 million senior secured facility earmarked for automation of the farms that remain after the Royal Oaks closure. The two facts belong together: a business under cost pressure looks for revenue in places that used to be liabilities, and spent substrate is the obvious candidate when the company already owns the composting site and the trucks that leave it.

Monaghan Mushrooms took the energy route first and the packaging route second. The largest business on this page, at about US$1.15 billion of revenue for 2025 with 12 vertically integrated farms and compost plants across six countries, recovers biomass energy to cut the gas burned in its growing rooms and has moved to fully recyclable paper and bio-based packaging. For a company whose crop is raised indoors at a fixed temperature, gas and electricity are not overheads but core inputs, so recovering energy from its own residue attacks the largest controllable cost inside the building.

For exporters the calculation is now part of the quotation. Shanghai Finc Bio-Tech reports about 98% purity and sells into more than 30 countries, and OKECHAMP S.A. reports about 85% purity across 12 markets with canned and frozen lines attached; both are selling to buyers who ask about carbon, packaging and waste before they discuss price. A grower in China or Poland prices the fate of its own substrate into the offer it makes, because the alternative is losing a listing to a competitor that can document a circular route through certification and energy recovery rather than describing one.

How to judge an ESG claim in this industry. Check whether the compost is certified and sold or simply given away, whether the energy recovery happens at the company's own growing rooms or is bought in as renewable power, whether the packaging change covers the whole range or a single line, and whether the claim holds in every country the company operates in. Monaghan's switch to recyclable paper and bio-based packaging, Monterey's certified compost and the substrate programmes described by the Japanese and Chinese producers are all verifiable in kind; the size of the benefit is the part a reader should treat with care.